All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news


← First12345...706Next →

hiv & aids news selected from other sources

  • Cardiovascular disease
    Cardiovascular Disease Risk Missed in Many HIV-Positive Veterans Despite Better Risk-Assessment Tool
    The Body | 3 hours ago

    A retrospective analysis using the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Guidelines and Pooled Cohort Equations (PCEs) for acute myocardial infarction (AMI) and cardiovascular disease (CVD) risk found that the PCE scores were a much better predictor of 10-year CVD risk than the Framingham risk score in a cohort of more than 15,000 HIV-positive veterans on antiretroviral therapy, according to a presentation at ICAAC 2014, made by Henning Drechsler, M.D., of the University of Texas Southwestern Medical Center.

  • PrEP
    PrEP Pops Up On Cruising Sites
    Positive Lite | 3 hours ago

    We are now seeing the emergence of profiles where guys self-identify as PrEP users on cruising sites and apps like Grindr and Squirt. Is this a signal that PrEP is now a part of gay men’s sex lives? I decided to check out one of these sites to see what was happening.

  • Hepatitis C treatment
    Ireland: Hepatitis C drug to be made available
    The Irish Times | 3 hours ago

    Minister for Health Leo Varadkar is to make available potentially life-saving treatments for hepatitis C – provided agreement on price can be reached with the manufacturers.

  • Tuberculosis and HIV
    2014 Report on Tuberculosis Research Funding Trends, 2005–2013
    TAG | 3 hours ago

    Worldwide, governments, foundations, and companies invested US$676.7 million in research to develop new drugs, vaccines, and diagnostics against tuberculosis (TB) in 2013—barely one-third of the US$2 billion that experts estimate the world must spend each year to end the global TB epidemic—according to an analysis released today by Treatment Action Group (TAG).

  • The search for a cure
    Challenges to Stem Cell Transplantation in HIV-Positive Patients | 3 hours ago

    Stem cell transplants have gained interest in the HIV community mainly because of their potential for curing HIV itself. However, stem cell transplants are mainly used to treat various forms of cancer in both HIV-negative and HIV-positive people.

  • Hepatitis C treatment
    Advocates Criticize Plans to Restrict N.Y. Hepatitis C Drugs
    Poz magazine news | 3 hours ago

    Advocates argue that the proposed criteria are dangerous for people living with the deadly liver disease.

  • History of HIV and AIDS
    The horror of the Ebola virus: learning lessons from the HIV and AIDS response of the 1980s and 90s
    Action Aid | 20 hours ago

    In this guest blog, leading HIV and AIDS activist and former CEO of the Terrence Higgins Trust, Sir Nicholas Partridge draws comparisons between the fight to defeat HIV and AIDS and Ebola and looks at how we can use this knowledge to limit Ebola's spread.

  • Policy
    WHO recommends steps to improve HIVAIDS control in Estonia
    World Health Organization | 21 October 2014

    Estonia is among 5 European Union/European Economic Area countries with the highest rates of HIV– 24.6 per 100 000 populations in 2013. While the number of new HIV cases has been decreasing in Estonia since 2001, more needs to be done to address shortcomings in HIV/AIDS surveillance, treatment and care in order to halt the epidemic.

  • Drug-resistant TB
    South Africa: Bedaquiline approved to treat multi-drug resistant tuberculosis
    Business Day | 21 October 2014

    The Medicines Control Council has approved Janssen Pharmaceutica's bedaquiline, the first drug specifically designed for treating multi-drug resistant tuberculosis (MDR-TB) to reach the market. Janssen is a subsidiary of Johnson & Johnson.

  • Epidemiology
    Uganda fails to keep up with demand for HIV drugs
    Key Correspondents | 20 October 2014

    Despite a remarkable increase in access to HIV treatment over the last decade, the number of people in need of antiretroviral drugs in Uganda continues to outpace the response.

← First12345...955Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.